Acute infection-inflammation and coronary stent thrombosis: An observational study

Internal and Emergency Medicine

Volumn 5, Issue 2, 2010, Pages 121-126

  Del Pace, Stefano ^a   Boddi, Maria ^a   Rasoini, Raffaele ^a   Micheli, Serena ^a   Alderighi, Camilla ^a   Caciolli, Sabina ^a   Margheri, Massimo ^a   Abbate, Rosanna ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; Coronary artery disease; Infection; Inflammation; Stent thrombosis

Indexed keywords

ACUTE DISEASE; AGED; ARTICLE; CORONARY ARTERY THROMBOSIS; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; INFECTION; INFLAMMATION; ITALY; MALE; MIDDLE AGED; PREVALENCE; RESTENOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; FEMALE; HUMANS; INFECTION; INFLAMMATION; ITALY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 77953357813     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0350-4     Document Type: Article

References (40)

1. Cutlip DE, Baim DS, Ho KK et al (2001) Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trial. Circulation 103: 1967-1971.
2. Moreno R, Fernandez C, Hernandez R et al (2005) Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45: 954-959.
3. Holmes DR Jr, Moses JW, Schofer J et al (2006) Cause of death with bare metal and sirolimus-eluting stents. Eur Heart J 27: 2815-2822.
4. Spaulding C, Daemen J, Boersma E et al (2007) A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. NEJM 356: 989-997.
5. Kastrati A, Mehilli J, Pache J et al (2007) Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. NEJM 356: 1030-1039.
6. Stone GW, Moses JW, Ellis SG et al (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. NEJM 356: 990-1008.
7. Lagerqvist B, James SK, Stenestrand U et al (2007) Long-term outcome with drug-eluting stents versus bare-metal stents in Sweden. NEJM 356: 1009-1019.
8. Mauri L, Hsieh WH, Massaro JM et al (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. NEJM 356: 1020-1029.
9. Honda Y, Fitzgerald PJ (2003) Stent thrombosis: an issue revisited in a changing world. Circulation 108: 2-5.
10. Ong AT, Hoye A, Aoki J et al (2005) Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45: 947-953.
11. Wenaweser P, Rey C, Eberli FR et al (2005) Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 26: 1180-1187.
12. Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293: 2126-2130.
13. Park DW, Park SW, Park KH et al (2006) Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98: 352-356.
14. Urban P, Gershlick AH, Guagliumi G et al (2006) Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 113: 1434-1441.
15. Matetzky S, Shenkman B, Guetta V et al (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109: 3171-3175.
16. Wenaweser P, Dorffler-Melly J, Imboden K et al (2005) Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45: 1748-1752.
17. Gurbel PA, Bliden KP, Samara W et al (2005) Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. J Am Coll Cardiol 46: 1827-1832.
18. Buonamici P, Marcucci R, Migliorini A et al (2007) Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49: 2312-2317.
19. Madjid M, Vela D, Khalili-Tabrizi H (2007) Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J 34: 11-18.
20. Smeeth L, Thomas SL, Hall AJ et al (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351: 2611-2618.
21. Meier CR, Jick SS, Derby LE et al (1998) Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 351: 1467-1471.
22. Smeeth L, Casas JP, Hingorani AD (2007) The role of infection in cardiovascular disease: more support but many questions remain. Eur Heart J 28: 1178-1179.
23. Valtonen V, Kuikka A, Syrjanen J (1993) Thrombo-embolic complications in bacteraemic infections. Eur Heart J 14(Suppl K): 20-23.
24. Maradit-Kremers H, Crowson CS, Nicola PJ (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52: 402-411.
25. Tsakraklides VG, Blieden LC, Edwards JE (1974) Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus. Am Heart J 87: 637-641.
26. (2004) ACC/AHA guidelines for the management of patients with ST elevation myocardial infarction. J Am Coll Cardiol 44: 671-719.
27. (2005) American Diabetes Association Standards of Medical Care in Diabetes. Diabetes Care 28 (Suppl 1): S4-S36.
28. Marcucci R, Paniccia R, Antonucci E et al (2007) Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy. Thromb Haemost 98: 844-851.
29. Marcucci R, Paniccia R, Antonucci E et al (2006) Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. Am J Cardiol 98: 1156-1159.
30. Vallance P, Collier J, Bhagat K (1997) Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 349: 1391-1392.
31. Bhagat K, Moss R, Collier J, Vallance P (1996) Endothelial "stunning" following a brief exposure to endotoxin: a mechanism to link infection and infarction? Cardiovasc Res 32: 822-829.
32. Prasad K (2004) C-reactive protein increases oxygen radical generation by neutrophils. J Cardiovasc Pharmacol Ther 9: 203-209.
33. Baldus S, Heeschen C, Meinertz T et al (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108: 1440-1445.
34. Coller BS (2005) Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol 25: 658-670.
35. Santilli F, Basili S, Ferroni P, Davì G (2007) CD40/CD40L system and vascular disease. Intern Emerg Med 2: 256-260.
36. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J et al (2004) Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90: 847-852.
37. Virmani R, Guagliumi G, Farb A et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109: 701-705.
38. Joner M, Finn AV, Farb A et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48: 193-202.
39. Wang TH, Bhatt DL, Topol EJ (2006) Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 27: 647-654.
40. Capodanno D, Angiolillo DJ (2009) Contemporary issues on clopidogrel therapy: a critical appraisal. Intern Emerg Med 4: 195-198.